Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 3701–3750 of 35128
each of LeighAnne G. Baker, Duncan J. Hawkesby, Allen P. Hugli, Michael J. King, Linda K. Massman, Rolf Stangl and Felicia Thornton resigned from his or her respective position as a member of the Company’s Board of Directors
each of LeighAnne G. Baker, Duncan J. Hawkesby, Allen P. Hugli, Michael J. King, Linda K. Massman, Rolf Stangl and Felicia Thornton resigned from his or her respective position as a member of the Company’s Board of Directors
Mr. Rikard resigned from his position as a member of the Company’s Board of Directors
each of LeighAnne G. Baker, Duncan J. Hawkesby, Allen P. Hugli, Michael J. King, Linda K. Massman, Rolf Stangl and Felicia Thornton resigned from his or her respective position as a member of the Company’s Board of Directors
On March 28, 2025, Mr. Christopher Egan provided notice of his resignation from the Board of Directors (the “Board”) of CCC Intelligent Solutions Holdings Inc. (the “Company”), effective immediately.
On March 20, 2025, Kent Wilson and Ian Kantrowitz submitted their resignations as members of the Board of Directors (the “Board”), serving in only an advisory capacity for the wind down of the Company, as needed.
On March 20, 2025, Kent Wilson and Ian Kantrowitz submitted their resignations as members of the Board of Directors (the “Board”), serving in only an advisory capacity for the wind down of the Company, as needed.
On March 31, 2025, effective upon the completion of the Distribution and pursuant to the employment transition agreement previously filed by the Company on January 13, 2025 with the Securities Exchange Commission as Exhibit 10.1 to the Current Report on Form 8-K dated January 13, 2025, Joseph Levin ceased to serve as Chief Executive Officer of the Company and as a member of the board of directors of the Company.
each of Christopher Halpin, Kendall F. Handler and Mark Stein notified Angi of his or her respective resignation from the Angi board of directors, effective as of March 31, 2025.
each of Christopher Halpin, Kendall F. Handler and Mark Stein notified Angi of his or her respective resignation from the Angi board of directors, effective as of March 31, 2025.
each of Christopher Halpin, Kendall F. Handler and Mark Stein notified Angi of his or her respective resignation from the Angi board of directors, effective as of March 31, 2025.
Neil Boehm, Kevin Nash and Scott Ryan joined Steven Downing as the directors of the Surviving Corporation
At the Effective Time, each of Ari M. Shalam, Patrick M. Lavelle, Beat Kahli, John J. Shalam, Denise Waund Gibson and John Adamovich, Jr. ceased to serve as directors of the Company
At the Effective Time, each of Ari M. Shalam, Patrick M. Lavelle, Beat Kahli, John J. Shalam, Denise Waund Gibson and John Adamovich, Jr. ceased to serve as directors of the Company
At the Effective Time, each of Ari M. Shalam, Patrick M. Lavelle, Beat Kahli, John J. Shalam, Denise Waund Gibson and John Adamovich, Jr. ceased to serve as directors of the Company
Neil Boehm, Kevin Nash and Scott Ryan joined Steven Downing as the directors of the Surviving Corporation
At the Effective Time, each of Ari M. Shalam, Patrick M. Lavelle, Beat Kahli, John J. Shalam, Denise Waund Gibson and John Adamovich, Jr. ceased to serve as directors of the Company
Neil Boehm, Kevin Nash and Scott Ryan joined Steven Downing as the directors of the Surviving Corporation
At the Effective Time, each of Ari M. Shalam, Patrick M. Lavelle, Beat Kahli, John J. Shalam, Denise Waund Gibson and John Adamovich, Jr. ceased to serve as directors of the Company
At the Effective Time, each of Ari M. Shalam, Patrick M. Lavelle, Beat Kahli, John J. Shalam, Denise Waund Gibson and John Adamovich, Jr. ceased to serve as directors of the Company
As of the Effective Time, and pursuant to the terms of the Merger Agreement, Sandy Spring’s directors and executive officers ceased serving as directors and executive officers of Sandy Spring.
As of the Effective Time, and pursuant to the terms of the Merger Agreement, Sandy Spring’s directors and executive officers ceased serving as directors and executive officers of Sandy Spring.
As of the Effective Time, and pursuant to the terms of the Merger Agreement, Sandy Spring’s directors and executive officers ceased serving as directors and executive officers of Sandy Spring.
Peggy Daitch, Tracey Dedrick, Benjamin Wineman and Eboh Okorie have resigned from their roles as directors
Peggy Daitch, Tracey Dedrick, Benjamin Wineman and Eboh Okorie have resigned from their roles as directors
Peggy Daitch, Tracey Dedrick, Benjamin Wineman and Eboh Okorie have resigned from their roles as directors
Peggy Daitch, Tracey Dedrick, Benjamin Wineman and Eboh Okorie have resigned from their roles as directors
The three directors of Sandy Spring mutually agreed by the Company and Sandy Spring, each of whom previously served as a member of the board of directors of Sandy Spring immediately prior to the Merger and was appointed by the Board to fill the vacancies resulting from the increase in the size of the Board referred to above, in each case effective as of the Effective Time, are as follows: Daniel J. Schrider, Mona Abutaleb Stephenson and Mark C. Micklem (collectively, the “New Directors”).
The three directors of Sandy Spring mutually agreed by the Company and Sandy Spring, each of whom previously served as a member of the board of directors of Sandy Spring immediately prior to the Merger and was appointed by the Board to fill the vacancies resulting from the increase in the size of the Board referred to above, in each case effective as of the Effective Time, are as follows: Daniel J. Schrider, Mona Abutaleb Stephenson and Mark C. Micklem (collectively, the “New Directors”).
The three directors of Sandy Spring mutually agreed by the Company and Sandy Spring, each of whom previously served as a member of the board of directors of Sandy Spring immediately prior to the Merger and was appointed by the Board to fill the vacancies resulting from the increase in the size of the Board referred to above, in each case effective as of the Effective Time, are as follows: Daniel J. Schrider, Mona Abutaleb Stephenson and Mark C. Micklem (collectively, the “New Directors”).
On March 27, 2025, W. Thorpe McKenzie informed the Board of Directors (the “Board”) of XBiotech Inc. (the “Company”) via letter of his decision to retire from the Board, effective immediately.
Simon Tate notified Climb Bio, Inc. (the “Company”) of his decision to resign as a member of the Company’s board of directors
Mr. Cumbo was elected to serve with a term expiring at the Company’s 2026 annual meeting of stockholders and thereafter until his successor has been duly appointed and qualified or until his earlier death, resignation or removal.
Ms. Drapkin was elected to serve with a term expiring at the Company’s 2027 annual meeting of stockholders and thereafter until her successor has been duly appointed and qualified or until her earlier death, resignation or removal.
Adam Rosenberg notified the Company that he does not intend to seek re-election as a member of the Board when his current term ends at the Company’s 2025 annual meeting of stockholders.
On March 31, 2025, Todd M. Ricketts notified the Board of Directors (the “Board”) of The Charles Schwab Corporation of his intention to retire from the Board effective October 7, 2025.
On March 28, 2025, Ng Ah Lek resigned from his positions as an Independent Director of Graphjet Technology (the “Company”) and as a member of the Company’s Audit Committee, Renumeration Committee, and Nominating and Corporate Governance Committee.
Effective April 1, 2025, following ten years of board membership, Israel Niv retired as a member of the board of directors (the “Board”) of Actelis Networks, Inc. (the “Company”), and as member of the committees of the Board.
On April 1, 2025, iHeartMedia, Inc. (the “Company”) announced that it intends to nominate Robert Millard as a director of the Company at the Company’s 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”).
On March 26, 2025, Brad Gerstner informed the Company of his intention not to stand for re-election to the Board at the Company’s 2025 Annual Meeting to focus on other commitments and accordingly, his term will end on the date of the 2025 Annual Meeting.
Frank E. Jenkins, Jr., a former director of Village, was appointed to the board of directors of TowneBank effective as of the effective time of the Transaction.
On March 31, 2025, the Board appointed Lawrence S. Massaro to serve as a member of the board of directors (the “ Board ”) of TXO Partners GP, LLC (the “ General Partner ”), the general partner of TXO Partners, L.P. (the “ Partnership ”), effective April 1, 2025.
Effective as of April 1, 2025, Salvatore Mulia, a member of the NewtekOne, Inc. Board of Directors (the “Board”) since 2004, retired as a member of the Board.
will continue to serve on the Board until the end of his term, which expires May 15, 2025
Kevin W. Bush as an outside director
the retirement of Wm. Ronald Duffey on March 31, 2025
Ronnie M. Hendricks as a member at-large director
Christopher L. Stephens as a director for member group 3
On April 1, 2025, Antonio M. Gotto, Jr., M.D., D. Phil. notified the Board of the Company of his decision to resign from the Board, including his position as a member of the Nominating and Corporate Governance Committee of the Board (the “Nominating and Corporate Governance Committee”), effective June 1, 2025.
On April 1, 2025, Nicole Vitullo notified the Board of Directors (the “Board”) of Esperion Therapeutics, Inc. (the “Company”) of her decision to resign from the Board, including her positions as a member of the Audit Committee of the Board (the “Audit Committee”) and Compliance Committee of the Board, effective June 1, 2025.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.